Question Title

* 1. Where is your clinic based?

Question Title

* 2. How likely are you to refer to the RACGP’s Australian type 2 diabetes management algorithm to assist you with prescribing decisions?

Question Title

* 3. Thinking about your 2nd and 3rd line prescribing practices for T2D, which of these statements is true for you? (Answer YES or NO for each option)

  Yes No
I tend to favour an SGLT2i for suitable patients
I tend to favour a GLP-1RA for suitable patients
I am confident prescribing an SGLT2i or GLP-1RA
I am more likely to prescribe insulin
I am more comfortable with the older DPP4-i or SU classes

Question Title

* 4. Would you say you have an adequate understanding of the GLP-1RA mechanism of action? (Answer on a scale of 1-5 with 1 being low understanding and 5 being high understanding

i We adjusted the number you entered based on the slider’s scale.

Question Title

* 5. Which of the following combinations do you consider to be clinically advantageous? (Answer YES or NO for each option)

  Yes No
SGLT2i with a GLP-1RA
GLP-1RA with insulin
GLP-1RA with a DPP-4i

Question Title

* 6. Which of the following combinations are you currently prescribing? (Answer YES or NO for each option)

  Yes No
SGLT2i with a GLP-1RA
GLP-1RA with insulin
GLP-1RA with a DPP-4i
Metformin with a SU

Question Title

* 7. What, if any, are your biggest challenges for prescribing a GLP-1RA? (Answer YES or NO for each option)

  Yes No
Unfamiliarity with prescribing this class
Gastrointestinal side effects
Hypoglycaemia
PBS restrictions for this class
Time/resources required for initiation of injectable
Patient aversion to injectables
Patient concern about additional cost
Patient concern about multiple therapies
Patient concept of injectables being end stage

Question Title

* 8. What do you think are the main benefits of a GLP-1RA? (Answer YES or NO for each option)

  Yes No
Efficacy
Weight loss
Cardiovascular safety
Once-weekly administration
Side effect profile
Patient compliance

Question Title

* 9. Of the following GLP-1RAs which are you most likely to prescribe for a suitable patient?

Question Title

* 10. What type of support would be beneficial to assist you with initiation of a GLP-1RA? (Answer YES or NO for each option)

  Yes No
Access/sponsorship to a diabetes educator
Access to faster referral pathways
Nurse practitioner on site
Nurse practitioner virtually
CPD accredited education
Drug samples
Pharma company meetings

Question Title

* 11. In general, what do you find most challenging about treating and managing patients with diabetes? (Choose three of the following)

0 of 12 answered
 

T